Niva Bupa Health Insurance Company Limited

Niva Bupa Authorizes KMPs for Materiality Disclosures Under SEBI Listing Regulations

Niva Bupa Health Insurance Company Limited has authorized its Key Managerial Personnels (KMPs) to determine and disclose material events to stock exchanges as per SEBI regulations. The authorized KMPs are Krishnan Ramachandran, Vishwanath Mahendra, and Aparna Sharma. This update is effective January 29, 2026.

Niva Bupa Appoints Roger Davis as Additional Director, Aparna Sharma as Company Secretary

Niva Bupa appointed Roger William John Davis as Additional Director and Aparna Sharma as Company Secretary and Compliance Officer. Both appointments are effective January 29, 2026. Davis brings 40 years of financial services experience, while Sharma has over 15 years in corporate governance.

Niva Bupa Appoints Roger Davis as Director, Aparna Sharma as Company Secretary

Niva Bupa Health Insurance appointed Roger William John Davis as Additional Director and Aparna Sharma as Company Secretary and Compliance Officer, both effective January 29, 2026. Mr. Davis has 40 years of financial services experience, while Ms. Sharma brings over 15 years in corporate governance.

Niva Bupa Appoints Roger Davis as Additional Director, Aparna Sharma as Company Secretary

Niva Bupa Health Insurance appointed Roger William John Davis as an Additional Director and Aparna Sharma as Company Secretary and Compliance Officer, both effective January 29, 2026. Davis brings 40 years of financial services experience, while Sharma has over 15 years in corporate governance.

Niva Bupa Q3 FY26 PAT Surges 74% to ₹208 Cr on Strong Premium Growth

Niva Bupa reported a 74% surge in PAT for 9M FY26, reaching ₹208 crore. Q3 FY26 PAT was over ₹76 crore. GWP grew 55% YoY to ₹2,231 crore in Q3 FY26. Retail health market share increased to 10.2%. Customer base grew 23% to 24.5 million lives insured.

Niva Bupa Health Insurance Board Approves Q3 FY26 Unaudited Financial Results

Niva Bupa Health Insurance Company Limited's Board approved its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The company has applied for forbearance from IRDAI regarding expenses of management.

Niva Bupa to Host Q3FY26 Earnings Conference Call on Jan 29, 2026

Niva Bupa Health Insurance Company Limited has scheduled an Earnings conference call for analysts and investors on January 29, 2026. The call will discuss the company's performance for the quarter and nine-months ended December 31, 2025.

Niva Bupa submits SEBI Reg 74(5) certificate for Q3 FY26

Niva Bupa Health Insurance Company Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended December 31, 2025. The Registrar confirmed no demat requests were processed as no shares are held in physical form.

Niva Bupa Allots 88,000 Equity Shares Under ESOP 2020 on Dec 30, 2025

Niva Bupa Health Insurance Company Limited allotted 88,000 equity shares on December 30, 2025, under its ESOP 2020. The shares have a face value of ₹10 each and will rank pari-passu with existing equity shares.

Niva Bupa Health Insurance Trading Window Closed Jan 1, 2026 for Q4 Results

Niva Bupa Health Insurance's trading window will be closed from January 1, 2026, for designated persons and immediate relatives. This closure is in anticipation of the unaudited financial results for the quarter ending December 31, 2025. The company will announce the Board meeting date for results consideration separately.

Niva Bupa Health Insurance Receives Independent ESG Rating of 65.3 for FY24-25

Niva Bupa Health Insurance received an independent ESG rating of 65.3 for FY24-25 from SES ESG Research. The rating agency assigned this score based on publicly available data without prior engagement from the company. The rating was communicated on December 16, 2025.

Niva Bupa: Postal Ballot Results - Resolutions Approved December 04, 2025

Niva Bupa announces postal ballot results with all resolutions approved, including the appointment of Vivek Anant Karve as an Independent Director and remuneration for Vivek Anant Karve and Milind Gajanan Barve.

Niva Bupa Allots Equity Shares Under ESOP Scheme 2020

Niva Bupa Health Insurance Company Limited has allotted 11,11,500 Equity Shares under its ESOP Scheme 2020 on November 13, 2025. The shares have a face value of ₹10 each.

IRDAI approves DSP Asset Managers' acquisition of Niva Bupa shares

IRDAI approves the acquisition of up to 11,53,14,606 equity shares of Niva Bupa by DSP Asset Managers Private Limited.

Niva Bupa to participate in Avendus Spark INDX 2025 – Annual Investor Conference

Niva Bupa will attend Avendus Spark INDX 2025 Annual Investor Conference on November 19, 2025, in Mumbai. No price sensitive information will be shared.

Niva Bupa Q2 FY26 Earnings Call Transcript

Niva Bupa released Q2 FY26 earnings call transcript. H1 saw 23% growth, ₹132 crore PAT, and a combined ratio of 103.1%. GST reduction is expected to boost demand.

Niva Bupa Publishes Unaudited Financial Results for Quarter Ended September 30, 2025

Niva Bupa announces unaudited financial results for the quarter ended September 30, 2025, reporting a net loss of ₹3,527 Lakhs and gross premium income of ₹1,84,307 Lakhs.

Niva Bupa Dispatches Postal Ballot Notice

Niva Bupa dispatches postal ballot notice to members on November 3, 2025, for e-voting on resolutions, with e-voting commencing on November 5 and results expected by December 5.

Niva Bupa releases audio recording of earnings call for Q2 & H1 FY26 financial results

Niva Bupa released the audio recording of its November 03, 2025 earnings call, discussing unaudited financial results for the quarter and half year ended September 30, 2025.

Niva Bupa's Q2 FY26 PAT Doubles to ₹62 Cr; Retail Health GWP Up 24.5% YoY

Niva Bupa's Q2 FY26 PAT more than doubled to ₹62 crore, with Retail Health GWP up 24.5% YoY, reflecting strong operational performance and improved financial health.

Niva Bupa Reports Strong H1'FY2026 Results with 22.9% GWP Growth and New Product Launch

Niva Bupa reported strong H1'FY2026 results with GWP growing 22.9% to ₹3,983 crore and PAT at ₹132 crore. The company launched 'ReAssure 3.0' and improved its Combined Insurance Service Ratio.

Statement on deviation or variation for quarter ended September 30, 2025

Niva Bupa reports no deviation in the utilization of ₹800 crore IPO funds for the quarter ended September 30, 2025, as reviewed by the audit committee.

Niva Bupa Approves Unaudited Financial Results for Quarter Ended Sep 30, 2025

Niva Bupa's board approved unaudited financial results for the quarter ended September 30, 2025, reporting a net loss of ₹(3,527) Lakhs and addressing concerns about exceeding expense management limits.

Niva Bupa Announces Postal Ballot for Director Appointment and Remuneration

Niva Bupa announces postal ballot for member approval on director appointment and remuneration. E-voting: Nov 05 - Dec 04, 2025. Results by Dec 05, 2025.

Resignation of Company Secretary and Compliance Officer

Rajat Sharma, Company Secretary and Compliance Officer of Niva Bupa, has resigned effective October 31, 2025, to pursue external opportunities.

Niva Bupa schedules Q2FY26 earnings call for November 3, 2025

Niva Bupa announced an earnings call on November 3, 2025, to discuss the unaudited financial results for the quarter and half year ended September 30, 2025.

Niva Bupa files certificate under SEBI (Depositories and Participants) Regulations, 2018

Niva Bupa filed its Regulation 74(5) certificate for the quarter ended September 30, 2025, confirming no demat requests were received during the period.

Niva Bupa Receives Favorable Order in GST Dispute

IRDAI approves Milind Barve as Chairman of Niva Bupa Health Insurance Board

Niva Bupa Appoints Vivek Anant Karve as Independent Director

Mr. Chandrashekhar Bhaskar Bhave ceases as Niva Bupa Independent Director and Chairman

Niva Bupa to attend Motilal Oswal's 21st Annual Global Investor Conference

Submission of Scrutinizer’s Report on e-voting at 17th AGM

Niva Bupa holds 17th Annual General Meeting, approves financial statements and key appointments

Niva Bupa Q1 FY26 Earnings: PAT Doubles to ₹70 Crore, GWP Grows 28%

Newspaper Publication of Unaudited Financial Results for June 2025 Quarter

Niva Bupa Announces 17th Annual General Meeting on August 26, 2025

Niva Bupa Grants 2,70,000 Employee Stock Options Under ESOP Scheme 2024

Niva Bupa Announces Availability of Q1 FY26 Earnings Call Audio Recording

Niva Bupa informs shareholders about 17th AGM and Annual Report availability

Niva Bupa Announces 17th Annual General Meeting on August 26, 2025

Niva Bupa Approves Unaudited Financial Results for Quarter Ended June 30, 2025

Niva Bupa reports no deviation in IPO fund utilization for June 2025 quarter

Niva Bupa Q1'FY26: GWP ₹1,631.9 Cr, PAT ₹70.1 Cr (IFRS), Retail Health Market Share 10%

Niva Bupa Approves Unaudited Financial Results for Quarter Ended June 30, 2025

Niva Bupa to hold 17th Annual General Meeting on August 26, 2025

Niva Bupa Health Insurance to Host Q1FY26 Earnings Call on July 31, 2025

Independent Director Sridhar Srinivasan Resigns